Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
复制标题
DOI：
10.1053/euhj.2000.2305
复制
发表时间：
2000-09-01
影响因子：
39.3
通讯作者：
Wood, D
中科院分区：
文献类型：
--
作者：
Alpert, JS;Antman, E;Wood, D
摘要......967 MI的定义......967书目......967病理学......967生物化学......967心电图仪......968成像......968流行病学......968附录A......968附录B......969附录C......本文件由欧洲心脏病学会(ESC)主席Lars Rydén医学博士和美国心脏病学会(ACC)主席Arthur Garson医学博士正式批准后，由医学博士Kristian Thygesen和医学博士Joseph S.Alpert发起的共识会议制定。所有参与者都是根据他们所代表的领域的专门知识而被挑选出来的，大约一半的参与者是从每个组织中挑选出来的。与会者被指示审查其专长领域的科学证据，并带着事先准备好的发言稿出席协商一致会议。该文件的初稿是在协商一致会议期间编写的。资金来源见附录A。本文件中提出的建议代表了与会者在会议期间的态度和意见，这些建议后来进行了修订。随着新的科学证据的出现，得出的结论无疑需要修改。这份文件已由科学和临床倡议委员会的成员以及于2000年4月15日批准该文件的科学和临床倡议委员会董事会成员审阅。∗∗
Summary...... 967Definition of MI...... 967Bibliography...... 967Pathology...... 967 Biochemistry...... 967 Electrocardiography...... 968 Imaging...... 968 Epidemiology...... 968Appendix A...... 968Appendix B...... 969Appendix C...... 969PreambleThis document was developed by a consensus conference initiated by Kristian Thygesen, MD, and Joseph S. Alpert, MD, after formal approval by Lars Rydén, MD, President of the European Society of Cardiology (ESC), and Arthur Garson, MD, President of the American College of Cardiology (ACC). All of the participants were selected for their expertise in the field they represented, with approximately one-half of the participants selected from each organization. Participants were instructed to review the scientific evidence in their area of expertise and to attend the consensus conference with prepared remarks. The first draft of the document was prepared during the consensus conference itself. Sources of funding appear in Appendix A. The recommendations made in this document represent the attitudes and opinions of the participants at the time of the conference, and these recommendations were revised subsequently. The conclusions reached will undoubtedly need to be revised as new scientific evidence becomes available. This document has been reviewed by members of the ESC Committee for Scientific and Clinical Initiatives and by members of the Board of the ESC who approved the document on April 15, 2000.∗∗